A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III)

International Journal of Stroke

Volumn 9, Issue 4, 2014, Pages 536-542

  Ziai, Wendy C ^a   Tuhrim, Stanley ^b   Lane, Karen ^c   Mcbee, Nichol ^c   Lees, Kennedy ^d   Dawson, Jesse ^d   Butcher, Kenneth ^e   Vespa, Paul ^f   Wright, David W ^g   Keyl, Penelope M ^c   Mendelow, A David ^h   Kase, Carlos ⁱ   Wijman, Christine ^j   Lapointe, Marc ^k   John, Sayona ^l   Thompson, Richard ^m   Thompson, Carol ^m   Mayo, Steven ⁿ   Reilly, Pat ^o   Janis, Scott ^p   Awad, Issam ^q   Hanley, Daniel F ^c   more..

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

ⁱ BOSTON MEDICAL CENTER   (United States)

^j Stanford California and Cofounder   (United States)

^k MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^l RUSH UNIVERSITY MEDICAL CENTER   (United States)

^m JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ Emissary International LLC   (United States)

^o GENENTECH INC   (United States)

^p NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^q UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

Intracerebral haemorrhage; Protocols; Randomized clinical trial; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD VOLUME; BRAIN FOURTH VENTRICLE; BRAIN HEMORRHAGE; BRAIN THIRD VENTRICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FIBRINOLYTIC THERAPY; FUNCTIONAL STATUS; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LOW DRUG DOSE; MORTALITY; MULTICENTER STUDY; NEUROIMAGING; OBSTRUCTIVE HYDROCEPHALUS; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; VENTRICULOSTOMY CATHETER; ADOLESCENT; BRAIN VENTRICLE; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPLICATION; COMPUTED TOMOGRAPHY SCANNER; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899993090     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12097     Document Type: Article

References (37)

1. Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 1998; 29:1352-1357.
2. Tuhrim S, Dambrosia JM, Price TR etal. Prediction of intracerebral hemorrhage survival. Ann Neurol 1988; 24:258-263.
3. Steiner T, Schneider D, Mayer S etal. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006; 59:767-773.
4. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med 1995; 23:950-954.
5. Conway JE, Oshiro EM, Piantadosi S. Ventricular blood is an admission ct variable which predicts poor clinical outcome after aneurysmal subarachnoid hemorrhage. American association of neurological surgeons annual meeting, Philadelphia, Pennsylvania. J Neurosurg 1998; 88:398A.
6. Mendelow AD, Gregson BA, Fernandes HM etal.; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (stich): a randomised trial. Lancet 2005; 365:387-397.
7. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD; STICH Investigators. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl 2006; 96:65-68.
8. Steiner T, Diringer MN, Schneider D etal. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006; 59:767-773.
9. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27:617-621.
10. Carhuapoma JR. Thrombolytic therapy after intraventricular hemorrhage: do we know enough? J Neurol Sci 2002; 202:1-3.
11. Naff NJ, Williams MA, Rigamonti DR, Keyl PM, Hanley DF. Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery 2001; 49:614-619; discussion 619-621.
12. Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology 1998; 50:519-523.
13. Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg 1994; 80:805-809.
14. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 3: effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 1986; 19:553-572.
15. Steinke W, Sacco RL, Mohr JP. Thalamic stroke. Presentation and prognosis of infarcts and hemorrhages. Arch Neurol 1992; 49:703-710.
16. Lee KR, Betz AL, Kim S, Keep RF, Hoff JT. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir (Wien) 1996; 138:396-401.
17. Ellington E, Margolis G. Block of arachnoid villus by subarachnoid hemorrhage. J Neurosurg 1969; 30:651-657.
18. Kibler RF, Couch RSC, Crompton MR. Hydrocephalus in the adult following spontaneous hemorrhage. Brain 1961; 84:45-61.
19. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 2: in vivo safety study of intraventricular urokinase. Neurosurgery 1986; 19:547-552.
20. Mayfrank L, Kissler J, Raoofi R. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 1997; 28:141-148.
21. Coplin WM, Vinas FC, Agris JM etal. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998; 29:1573-1579.
22. Naff NJ, Carhuapoma JR, Williams MA etal. Treatment of intraventricular hemorrhage with urokinase: effects on 30-Day survival. Stroke 2000; 31:841-847.
23. Naff NJ, Hanley DF, Keyl PM etal. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, doubleblind, controlled trial. Neurosurgery 2004; 54:577-583.
24. Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular hemorrhage. Acta Neurochir (Wien) 1995; 134:55-59.
25. Akdemir H, Selçuklu A, Pasaoglu A, Oktem IS, Kavuncu I. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 1995; 18:95-100.
26. Vereecken KK, Van Havenbergh T, De Beuckelaar W, Parizel PM, Jorens PG. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator: a clinical study of 18 cases. Clin Neurol Neurosurg 2006; 108:451-455.
27. Bartek J Jr, Hansen-Schwartz J, Bergdal O etal. Alteplase (rt-PA) treatment of intraventricular hematoma (IVH): safety of an efficient methodological approach for rapid clot removal. Acta Neurochir Suppl 2011; 111:409-413.
28. Dunatov S, Antoncic I, Bralic M, Jurjevic A. Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage. Acta Neurol Scand 2011; 124:343-348.
29. Staykov D, Huttner HB, Struffert T etal. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 2009; 40:3275-3280.
30. Huttner HB, Tognoni E, Bardutzky J etal. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 2008; 15:342-349.
31. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage byintraventricular infusion of urokinase. J Neurosurg 1991; 74:81-86.
32. Torres A, Plans G, Martino J etal. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg 2008; 22:269-274.
33. Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998; 12:234-239.
34. Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev 2002; (3):CD003692.
35. Gaberel T, Magheru C, Emery E, Derlon JM. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien) 2012; 154:1-9.
36. Naff N, Williams M, Keyl PM etal. Low-dose rt-PA enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 2011; 42:3009-3016.
37. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D etal.; PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012; 11:307-314.